ResearcherErasmus MCNo recent work listed

Wesley K. Utomo

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5113799375. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2014: 1 paper

Papers 1

mTOR is a promising therapeutical target in a subpopulation of pancreatic adenocarcinoma. Co-author DOI 10.1016/j.canlet.2014.01.014 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Maikel Petrus Peppelenbosch · 1 shared paper, 2014 · strength 0.05
- Paper mTOR is a promising therapeutical target in a subpopulation of pancreatic adenocarcinoma. DOI 10.1016/j.canlet.2014.01.014 ↗
Henri Braat · 1 shared paper, 2014 · strength 0.05
- Paper mTOR is a promising therapeutical target in a subpopulation of pancreatic adenocarcinoma. DOI 10.1016/j.canlet.2014.01.014 ↗
Marco J. Bruno · 1 shared paper, 2014 · strength 0.05
- Paper mTOR is a promising therapeutical target in a subpopulation of pancreatic adenocarcinoma. DOI 10.1016/j.canlet.2014.01.014 ↗
Casper H.J. van Eijck · 1 shared paper, 2014 · strength 0.05
- Paper mTOR is a promising therapeutical target in a subpopulation of pancreatic adenocarcinoma. DOI 10.1016/j.canlet.2014.01.014 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.